As far as shotgun proteomics is concerned, it’s an approach that’s had a “fantastic impact on cell biology,” said Daniel Liebler, director of the proteomics lab at the Mass Spectrometry Research Center at Vanderbilt University. “But it hasn’t really hit clinical proteomics because it’s hard to do it a high-throughput standardized way.”
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.